the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid...

in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.. january 2007  (23). february 2014  (15).

. and our daily headlines will be delivered to your inbox each morning.